The present study demonstrates that caspase-3s, generated by alternative splicing of caspase-3 pre-mRNA, negatively interferes with caspase-3 activation and apoptosis in breast cancer cells exposed to cytotoxic drugs. The gene discussed is CASP3; the disease is breast carcinoma.